Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area.

By C. Booth, L. Matukas, George Tomlinson, A. Rachlis, D. Rose, Hy A Dwosh, S. Walmsley, T. Mazzulli, M. Avendano, P. Derkach and 11 more. Journal of the American Medical Association (JAMA), 2003

1,330 citations recorded by the source corpus.

Subfields: Epidemiology, Infectious Diseases

View Paper: https://www.semanticscholar.org/paper/82031522e8d992c47635e110206c4be8cc99eac4

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Epidemiology

In Infectious Diseases

Citations in the corpus

COVID-19 and Cardiovascular Disease (2020, background): “Among humans, during the Toronto SARS outbreak, SARS-CoV viral RNA was detected in 35% of autopsied hearts.(29) Other suggested mechanisms of COVID-19 related cardiac involvement include a cytokine storm, mediated by an imbalanced response among subtypes of T helper cells(20), and hypoxia induced ex”
Binding of SARS coronavirus to its receptor damages islets and causes acute diabetes (2009, methodology): “The diagnostic criteria for SARS, defined by the Chinese Ministry of Health, are similar to those of the Centers for Disease Control and Prevention (CDC) [6] .”
Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis (2020, background): “Since November 2019, the rapid outbreak of coronavirus disease 2019 (Covid- 19) , which arose from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, has recently become a public health emergency of international concern [1] .”
Association of Blood Glucose Control and Outcomes in Patients with COVID-19 and Pre-existing Type 2 Diabetes (2020, background): “The percentage of known T2D history was significantly higher among patients who succumbed to SARS than who survived (Booth et al., 2003; Yang et al., 2006).”
Potential interventions for novel coronavirus in China: A systematic review (2020, background): “Because there was a report mentioned that ribavirin had no significant activity against SARS‐CoV in vitro(52) and the use of ribavirin was found to be associated with significant toxicity, including hemolysis (in 76%) and decrease in hemoglobin (in 49%).(99) However, Morgenstern et al(49) had report”
SARS: Systematic Review of Treatment Effects (2006, background): “Four publications presented evidence of possible harm (14) (15) (16) (17) .”
Multiple organ infection and the pathogenesis of SARS (2005, background): “It was reported that lymphopenia is one of the earliest changes, and is a reliable prognostic predictor in SARS (13) (14) (15) (16) (17) (18) .”
Is diabetes mellitus associated with mortality and severity of COVID-19? A meta-analysis (2020, positive): “Severe acute respiratory syndrome (SARS) outbreak in 202-2004 and Middle East Respiratory Syndrome (MERS) outbreaks in 2012 and 2015, had also resulted in increased severity and fatality in patients with diabetes mellitus [31] [32] [33] [34] [35] .”
The pivotal link between ACE2 deficiency and SARS-CoV-2 infection (2020, positive): “[57, 58] In a study conducted in 201 patients infected with SARS-CoV-2, most patients were men (63.7% of patients), the mean age was 51 years and the most frequent comorbidities were hypertension (19.4%), diabetes (10.9%) and history of cardiovascular disease (4.0).”
Coronavirus Pathogenesis and the Emerging Pathogen Severe Acute Respiratory Syndrome Coronavirus (2005, background): “Concurrent gastrointestinal symptoms and diarrhea, with active replication of SARS-CoV in both the small and large intestines, are common (19, 179, 182, 240).”